The late asthmatic response.
Since LARs are associated with increases in airways reactivity, their significance may go well beyond the increase in symptoms due just to the allergen exposure. This is especially true since the increase in non-specific airways reactivity can last for weeks after a single exposure to allergen. Every effort should be made to search for possible allergic triggers in patients suspected to have LARs. Careful attention to historical information and skin test reactivity are critical in this evaluation. In situations where this approach is not revealing and where serious concerns remain about potential environmental triggers, a bronchial challenge to the suspected antigen can be considered. Since the nonspecific airways reactivity in patients with LAR may possibly be due to inflammation in the airways, the potential risk of transient induction of airways inflammation must be carefully weighed against the value of information that can be obtained from this procedure. Bronchial challenge should be performed only in an inpatient setting by experienced personnel under the supervision of a physician. A full explanation of the potential risks and benefits of this type of evaluation must be given to the patient and family. Treatment is primarily directed at allergen avoidance with use of a prophylactic drug, such as cromolyn sodium, when allergen avoidance is not possible.
D000485:Allergens / Q000276:immunology; D001249:Asthma / Q000175:diagnosis / Q000503:physiopathology*; D002648:Child; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000473:pathology; D006969:Hypersensitivity, Immediate / Q000473:pathology; D012621:Seasons; D013997:Time Factors
D000485:Allergens